Bariatric surgery effective against early-onset obesity too

February 21, 2020

Surgical treatment of obesity is as effective for individuals who developed the disorder early, by the age of 20, as for those who have developed obesity later in life, a study from the University of Gothenburg shows.

The results, published in the journal Diabetes Care, are based on data from the Swedish Obese Subjects (SOS) study. Started in 1987, this study is led and coordinated from Sahlgrenska Academy at the University of Gothenburg.

The present substudy covers a total of 4,026 adult individuals who had developed obesity. Half of them had undergone bariatric surgery and the other half were a control group. Each of the groups was divided into three subgroups, based on the participants' body mass index (BMI) at age 20: those of normal weight, those who were overweight, and those with obesity.

The researchers then investigated whether there was any difference in the effects of bariatric treatment for obesity among those who had developed the disorder before age 20, compared with those who developed it later in life.

One of the study's coauthors is Johanna Andersson Assarsson, Ph.D., researcher and study coordinator for SOS.

"We were somewhat surprised at the results. Since the group that had already developed obesity by the age of 20 had been exposed to obesity and its risks for longer periods, we'd expected that bariatric surgical treatment in these participants would be less effective in terms of weight loss and obesity-related sequelae than in the other group. But it wasn't like that," Andersson Assarsson says.

"On the contrary, the group with obesity at age 20 lost a little bit more weight after the operation, and there was no difference in effects on diabetes or its complications, cardiovascular disease or cancer, compared with individuals who developed obesity later in life."

For many diseases, early treatment is advantageous, but individuals with early-onset obesity have often had their disorder for a long time before bariatric surgery is considered. It has sometimes been speculated that bariatric surgical treatment would be less effective in these individuals because of their longer exposure to the adverse health effects of obesity.

"Here, we show that's not the case. And we think it's important that this information reaches people considering bariatric surgery for obesity and also health professionals who treat patients with obesity," says Johanna Andersson Assarsson.
-end-
Title: Effects of Bariatric Surgery in Early- and Adult-Onset Obesity in the Prospective Controlled Swedish Obese Subjects Study; https://care.diabetesjournals.org/content/early/2020/01/22/dc19-1909

University of Gothenburg

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.